Evidence map›Paper›PMID 30719329›Full record

ArticleEuropean journal of microbiology & immunology2018

Acute

Katja Fischer, Jan-Moritz Doehn, Christian Herr, Carolin Lachner, Annina Heinrich, Olivia Kershaw, Meike Voss, Max H Jacobson, Achim D Gruber, Matthias Clauss and 4 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of microbiology & immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Katja FischerCharité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Infectious Diseases and Respiratory Medicine, Berlin, Germany.
Jan-Moritz DoehnCharité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Infectious Diseases and Respiratory Medicine, Berlin, Germany.
Christian HerrDepartment of Internal Medicine V - Pulmonology, Allergology, Respiratory Intensive Care Medicine, University of the Saarland, Homburg Saar, Germany.
Carolin LachnerSeptomics Research Center, Jena University Hospital, Jena, Germany.
Annina HeinrichSeptomics Research Center, Jena University Hospital, Jena, Germany.
Olivia KershawDepartment of Veterinary Pathology, Freie Universität, Berlin, Germany.
Meike VossDepartment of Internal Medicine V - Pulmonology, Allergology, Respiratory Intensive Care Medicine, University of the Saarland, Homburg Saar, Germany.
Max H JacobsonPathology and Laboratory Medicine, IU School of Medicine, Indianapolis, Indiana, USA.
Achim D GruberDepartment of Veterinary Pathology, Freie Universität, Berlin, Germany.
Matthias ClaussIndiana Center for Vascular Biology and Medicine and Department of Cellular and Integrative Physiology, Indiana University, Indianapolis, Indiana, USA.
Martin WitzenrathCharité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Infectious Diseases and Respiratory Medicine, Berlin, Germany.
Robert BalsDepartment of Internal Medicine V - Pulmonology, Allergology, Respiratory Intensive Care Medicine, University of the Saarland, Homburg Saar, Germany.
Birgitt GutbierCharité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Infectious Diseases and Respiratory Medicine, Berlin, Germany.
Hortense SlevogtSeptomics Research Center, Jena University Hospital, Jena, Germany.
Jena University Hospital · DEFreie Universität Berlin · DESaarland University · DECharité - Universitätsmedizin Berlin · DEIndiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In chronic obstructive pulmonary disease (COPD), acute exacerbations and emphysema development are characteristics for disease pathology. COPD is complicated by infectious exacerbations with acute worsening of respiratory symptoms with

Indexed as

chronic smoke exposureCOPDEMAPIIemphysemaM. catarrhalis

Identifiers

PMID30719329
PMCPMC6348706
OpenAlexW2905054743

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.